Atul Ltd
Atul Ltd. is a diversified and integrated Indian chemical company (a part of Lalbhai Group, Gujarat). The products of the company are used in various Industries and come mainly under two segments, Life Science Chemicals and Performance and Other Chemicals under 9 Businesses. [1]
Since its incorporation, the company has manufactured many products for the first time in India Dyes including Vat Dyes, crop care chemicals, Phosgene, Carbamite, 2,4-D Acid, para Cresol, tissue culture raised date palms. [2]
- Market Cap ₹ 17,185 Cr.
- Current Price ₹ 5,837
- High / Low ₹ 7,590 / 5,720
- Stock P/E 53.2
- Book Value ₹ 1,737
- Dividend Yield 0.43 %
- ROCE 9.08 %
- ROE 6.60 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 3.36 times its book value
- The company has delivered a poor sales growth of 3.20% over past five years.
- Company has a low return on equity of 10.6% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2,029 | 2,439 | 2,637 | 2,595 | 2,834 | 3,514 | 4,038 | 4,093 | 3,731 | 5,081 | 5,428 | 4,726 | |
1,780 | 2,075 | 2,235 | 2,134 | 2,324 | 3,008 | 3,270 | 3,191 | 2,813 | 4,168 | 4,620 | 4,089 | |
Operating Profit | 249 | 364 | 402 | 461 | 510 | 505 | 768 | 902 | 918 | 913 | 807 | 637 |
OPM % | 12% | 15% | 15% | 18% | 18% | 14% | 19% | 22% | 25% | 18% | 15% | 13% |
22 | 36 | 9 | 37 | 57 | 30 | 38 | 83 | 109 | 82 | 86 | 68 | |
Interest | 33 | 33 | 26 | 28 | 25 | 13 | 7 | 9 | 9 | 9 | 8 | 11 |
Depreciation | 51 | 58 | 60 | 66 | 95 | 110 | 119 | 130 | 136 | 177 | 198 | 243 |
Profit before tax | 186 | 308 | 326 | 404 | 446 | 412 | 680 | 845 | 882 | 810 | 688 | 451 |
Tax % | 31% | 29% | 31% | 32% | 28% | 32% | 36% | 21% | 25% | 25% | 26% | 28% |
120 | 219 | 240 | 274 | 323 | 281 | 436 | 671 | 660 | 605 | 507 | 324 | |
EPS in Rs | 40.38 | 73.90 | 81.13 | 92.44 | 108.88 | 93.21 | 145.72 | 224.69 | 221.64 | 204.23 | 174.19 | 109.71 |
Dividend Payout % | 15% | 10% | 10% | 9% | 9% | 13% | 10% | 12% | 9% | 12% | 19% | 18% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 3% |
3 Years: | 8% |
TTM: | -13% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | -6% |
3 Years: | -20% |
TTM: | -38% |
Stock Price CAGR | |
---|---|
10 Years: | 23% |
5 Years: | 10% |
3 Years: | -11% |
1 Year: | -16% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 14% |
3 Years: | 11% |
Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 |
Reserves | 725 | 919 | 1,009 | 1,585 | 1,936 | 2,214 | 2,676 | 3,125 | 3,797 | 4,399 | 4,642 | 5,085 |
370 | 367 | 299 | 316 | 168 | 16 | 55 | 108 | 133 | 144 | 52 | 237 | |
440 | 502 | 485 | 535 | 591 | 749 | 783 | 880 | 976 | 1,117 | 1,028 | 1,125 | |
Total Liabilities | 1,564 | 1,818 | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,476 |
506 | 570 | 514 | 750 | 1,026 | 1,027 | 1,104 | 1,110 | 1,418 | 1,634 | 1,770 | 2,792 | |
CWIP | 66 | 59 | 112 | 180 | 59 | 96 | 172 | 368 | 250 | 420 | 1,033 | 281 |
Investments | 67 | 63 | 66 | 382 | 429 | 470 | 752 | 1,137 | 1,361 | 1,339 | 881 | 1,342 |
925 | 1,126 | 1,131 | 1,154 | 1,210 | 1,415 | 1,515 | 1,528 | 1,906 | 2,297 | 2,068 | 2,061 | |
Total Assets | 1,564 | 1,818 | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,476 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
187 | 152 | 306 | 401 | 392 | 356 | 404 | 881 | 718 | 231 | 707 | 667 | |
-116 | -83 | -167 | -375 | -175 | -129 | -408 | -782 | -645 | -163 | -469 | -683 | |
-78 | -60 | -124 | -39 | -212 | -207 | -1 | -111 | -52 | -57 | -257 | 38 | |
Net Cash Flow | -6 | 8 | 16 | -13 | 5 | 19 | -5 | -11 | 21 | 11 | -20 | 22 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 63 | 65 | 61 | 62 | 67 | 75 | 63 | 64 | 72 | 71 | 57 | 72 |
Inventory Days | 116 | 119 | 105 | 118 | 107 | 83 | 89 | 93 | 128 | 122 | 101 | 90 |
Days Payable | 92 | 89 | 69 | 87 | 86 | 93 | 66 | 88 | 121 | 90 | 69 | 84 |
Cash Conversion Cycle | 87 | 95 | 97 | 93 | 88 | 66 | 86 | 69 | 78 | 103 | 89 | 77 |
Working Capital Days | 71 | 76 | 75 | 82 | 84 | 78 | 75 | 60 | 68 | 83 | 69 | 103 |
ROCE % | 20% | 28% | 26% | 26% | 23% | 19% | 27% | 28% | 24% | 19% | 15% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 2d
- Communication To The Members Of The Company Regarding Presentation To The Analysts / Institutional Investors Covering Financial Results For The Year Ended On March 31, 2024 3 May
- Compliances-Reg.24(A)-Annual Secretarial Compliance 3 May
- Announcement under Regulation 30 (LODR)-Newspaper Publication 27 Apr
- Book Closure For Dividend 26 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
-
Financial Year 2010
from bse
Evolution of the company over the years
Atul was earlier one of the largest dyestuff manufacturing companies in India; however, through its strong R&D initiatives, JV with multinational companies, and acquisitions, Atul has expanded its product portfolio significantly over the last few years in the areas of aromatics, crop protection, polymers and pharma intermediates which are specialty chemicals as compared to conventional dyestuff products. This shift in product mix has led to better profitability which has also shown a greater degree of resilience compared to the scenario of around a decade back. [1]